Overview
Key stats
Fundamentals Sep 10- Open
- $166.06
- 52-wk high
- $192.85
- High
- $166.59
- 52-wk low
- $112.50
- Low
- $160.06
- Prev close
- $167.58
- Mkt cap
- $4.03B
- P/E
- 135.3x
- Volume
- 311.3K
- Fwd P/E
- 16.9x
- Beta
- 0.76
- P/S
- 1.9x
- P/B
- 1.9x
- Profit margin
- +1.4%
- Op margin
- +7.5%
- ROE
- +1.4%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsSmart money
Earnings
Earnings came in 34.9% above what analysts expected.
Earnings per share
$1.49 expected
What the street expects next
EPS expected
$2.06 to $2.16
Revenue expected
4 analysts
Last 30 days
Analysts raising estimates
Estimate drift
Change in 30 days
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $537.0M | $540.3M | $530.4M | $551.7M |
| Cost of what it sold | $336.1M | $338.2M | $357.3M | $316.6M |
| Gross profit | $200.9M | $202.1M | $173.1M | $235.1M |
| What it spent | ||||
| Research and development | $21.3M | $21.1M | $21.3M | $22.7M |
| Sales and admin | $152.8M | $155.8M | $154.6M | $151.9M |
| Other operating costs | $13.1M | — | -$33.4M | $21.3M |
| Total operating expenses | $187.2M | $176.9M | $142.4M | $195.9M |
| What was left | ||||
| Operating profit | $13.7M | $25.2M | $30.7M | $39.1M |
| Interest on debt | $19.8M | $24.8M | $19.8M | $18.6M |
| Profit before tax | -$4.1M | -$18.4M | -$4.6M | $23.1M |
| Tax | -$658.0K | -$2.7M | -$34.7M | $7.1M |
| Net profit | -$3.4M | -$15.7M | $30.1M | $19.1M |
| EBITDA | $66.6M | $60.8M | $29.0M | $141.3M |
Technicals
Price structure
This stock is under pressure, and looks oversold after a sharp drop.
Trend
Under pressure
25 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage leans bearish
Tone of tracked coverage
ICU Medical Insider Sold Shares Worth $1,116,675, According to a Recent SEC Filing
Leans bearishSep 2Icu medical chief financial officer Brian Bonnell sells $1.1 million in stock
NeutralSep 2ICU Medical Insider Sold Shares Worth $1,608,143, According to a Recent SEC Filing
Leans bearishSep 1ICUI Price History for I C U Medical Stock
NeutralAug 28ICU Medical rating upgraded by S&P on stronger credit metrics
BullishAug 28Otsuka ICU Medical breaks ground on 500,000 square foot Austin site expansion
NeutralAug 25
Macro
11 macro signals shaping ICUI right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results